1. Home
  2. HTBK vs PRTA Comparison

HTBK vs PRTA Comparison

Compare HTBK & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTBK
  • PRTA
  • Stock Information
  • Founded
  • HTBK 1997
  • PRTA 2012
  • Country
  • HTBK United States
  • PRTA Ireland
  • Employees
  • HTBK N/A
  • PRTA N/A
  • Industry
  • HTBK Major Banks
  • PRTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTBK Finance
  • PRTA Health Care
  • Exchange
  • HTBK Nasdaq
  • PRTA Nasdaq
  • Market Cap
  • HTBK 581.9M
  • PRTA 472.1M
  • IPO Year
  • HTBK 1998
  • PRTA N/A
  • Fundamental
  • Price
  • HTBK $10.54
  • PRTA $10.45
  • Analyst Decision
  • HTBK Strong Buy
  • PRTA Buy
  • Analyst Count
  • HTBK 4
  • PRTA 9
  • Target Price
  • HTBK $11.88
  • PRTA $17.71
  • AVG Volume (30 Days)
  • HTBK 404.8K
  • PRTA 567.7K
  • Earning Date
  • HTBK 10-23-2025
  • PRTA 11-06-2025
  • Dividend Yield
  • HTBK 4.91%
  • PRTA N/A
  • EPS Growth
  • HTBK N/A
  • PRTA N/A
  • EPS
  • HTBK 0.70
  • PRTA N/A
  • Revenue
  • HTBK $187,676,000.00
  • PRTA $11,786,000.00
  • Revenue This Year
  • HTBK $13.16
  • PRTA N/A
  • Revenue Next Year
  • HTBK $7.61
  • PRTA $672.02
  • P/E Ratio
  • HTBK $15.11
  • PRTA N/A
  • Revenue Growth
  • HTBK 10.94
  • PRTA N/A
  • 52 Week Low
  • HTBK $8.09
  • PRTA $4.32
  • 52 Week High
  • HTBK $11.27
  • PRTA $18.65
  • Technical
  • Relative Strength Index (RSI)
  • HTBK 56.78
  • PRTA 56.63
  • Support Level
  • HTBK $10.36
  • PRTA $10.02
  • Resistance Level
  • HTBK $10.82
  • PRTA $11.17
  • Average True Range (ATR)
  • HTBK 0.28
  • PRTA 0.56
  • MACD
  • HTBK 0.04
  • PRTA -0.07
  • Stochastic Oscillator
  • HTBK 67.11
  • PRTA 37.37

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: